Who should be included in first-in-human trials? A systematic review of reasons.

van Kempen L, de Vries MC, de Koning EJP, de Graeff N

DOI: 10.1186/s12967-025-06550-y
Published: 2025 Jun 11
Container: Journal of translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12967-025-06550-y,
  title = {Who should be included in first-in-human trials? A systematic review of reasons.},
  author = {van Kempen L and de Vries MC and de Koning EJP and de Graeff N},
  year = {2025},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-025-06550-y},
  url = {https://doi.org/10.1186/s12967-025-06550-y}
}

RIS

TY  - JOUR
TI  - Who should be included in first-in-human trials? A systematic review of reasons.
AU  - van Kempen L
AU  - de Vries MC
AU  - de Koning EJP
AU  - de Graeff N
PY  - 2025
JO  - Journal of translational medicine
DO  - 10.1186/s12967-025-06550-y
UR  - https://doi.org/10.1186/s12967-025-06550-y
ER  -

APA

L, V. K., MC, D. V., EJP, D. K., & N, D. G. (2025). Who should be included in first-in-human trials? A systematic review of reasons.. Journal of translational medicine. https://doi.org/10.1186/s12967-025-06550-y

Source records

pubmed · retrieved 2026-09-26T02:28:08.027Z